Antitumor activity of polyoxomolybdate, [NH3Pri]6[Mo7O24] ·3H2O, against, human gastric cancer model

Biomedicine and Pharmacotherapy

Volumn 60, Issue 7, 2006, Pages 353-358

  Mitsui, S ^a   Ogata, A ^a   Yanagie, H ^b   Kasano, H ^c   Hisa, T ^b   Yamase, T ^a   Eriguchi, M ^b  

^a TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c Polytronics Co LTD   (Japan)

Author keywords

Apoptosis; Cancer growth inhibition; Human gastric cancer; MKN45; Polyoxomolybdate

Indexed keywords

DNA FRAGMENT; HEXABIS(ISOPROPYLAMMONIUM)HEPTAMOLYBDATE; METAL OXIDE; MOLYBDIC ACID; POLYOXOMOLYBDATE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; MOLYBDENUM; OXIDE; PM 8;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL NUCLEUS; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; HUMAN; HUMAN CELL; IC 50; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; STOMACH CANCER; ANIMAL; DISEASE MODEL; GERMFREE ANIMAL; NUDE MOUSE; STOMACH TUMOR; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MICE; MICE, NUDE; MOLYBDENUM; OXIDES; SPECIFIC PATHOGEN-FREE ORGANISMS; STOMACH NEOPLASMS;

EID: 33748132276     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2006.02.009     Document Type: Article

References (30)

1. Yamase T. Antitumoral and antiviral polyoxometalates (Inorganic discrete polymer of metal oxide). CRC Press 1 (1996) 365-373
2. Yamase T. Medical Chemistry of Polyoxometalates. Part 1. Ptent Antitumor Activity of Polyoxomolybdates on Animal Transplantable Tumor and Human Cancer Xenograft. Inorg. Chim. Acta 151 (1988) 15-18
3. Fujita H., Fujita T., Sakurai T., and Seto Y. A new type of antitumor substances, polyoxomolybdates. Chemotherapy 40 (1992) 173-178
4. Ohashi Y., Yanagi K., Sasada Y., and Yamase T. Crystal structure and photochemistry of isopolymolybdates. I. The crystal structure of hexakis(propylammonium) heptamolybdate(VI) trihydrate and hexakis(isopropylammonium) heptamolybdate(VI) trihydrate. Bull. Chem. Soc. Japan 55 (1982) 1254-1260
5. Yamase T., and Ikawa T. Photochemical study of the alkylammonium molybdates. III. Preparation and Properties. Bull. Chem. Soc. Japan 50 (1977) 746-749
6. Maier F., Hesse B., and Kopf H. Tumor Inhibition by Metallocenes: Effect of Titanocene, Zirconocene, and Hafnocene Dichlorides on Ehrlich Ascites Tumor in Mice. Cancer Res. Clin. Oncol. 96 (1980) 43-51
7. Rawls R. Search for More Metal-containing Antitumor Agents Intensifies. Sci. Oct. 6 (1986) 21-22
8. 5). J. Inorg. Biochem. 94 (2003) 279-284
9. 25- and their biological activity. Polyhedron 17 (1998) 1541-1546
10. Wang X., Liu J., Li J., and Liu J. Synthesis, characterization and in vitro antitumor activity of diorganometallo complexes γ-Keggin anions. Inorg. Chem. Commun. 7 (2001) 372-374
11. Sarafinanos S.G., Kortz U., Pope M.T., and Modak M.J. Mechanism of polyoxometalate-mediated inactivation of DNA polymerases: an analysis with HIV-1 reverse transcriptase indicates specificity for the DNA-binding cleft. Biochem. J. 319 (1996) 619-626
12. Inoue Y., Fujimoto Y., Sugiyama M., Yoshida T., and Yamase T. Structure-activity correlationship and strain specificity of polyoxometalates in anti-human immunodeficiency virus activity. Biol Pharm. Bull. 18 (1995) 996-1000
13. Kim G.S., Judd D.A., Hill C.L., and Schinazi R.F. Synthesis, characterization, and biological activity of a new potent class of anti-HIV agents, the peroxoniobium-substituted heteropolytungstates. J. Med. Chem. 37 (1994) 816-820
14. Cholewa M., Legge G.J., Weigold H., Holan G., and Birch C.J. The use of a scanning proton microprobe to observe anti-HIV drugs within cells. Life Science 54 (1994) 1607-1612
15. Weeks M.S., Hill C.L., and Schinazi R.F. Synthesis, charasterization, and anti-human immunodeficiency virus activity of water-solution salts of polyoxotungstate anions with covalently attached organic groups. J. Med. Chem. 35 (1992) 1216-1221
16. Fukuma M., Seto Y., and Yamase T. In vitro antiviral activity of polyoxotungstate (PM-19) and other polyoxometalates against herpes simplex virus. Antiviral Res. 16 (1991) 327-339
17. Ikeda S., Nishiya S., Yamamoto A., Yamase T., Nishimura C., and De Clercq E. Activity of the Keggin polyoxotungstate PM-19 against herpes simplex virus type 2 infection in immunosuppressed mice: role of peritoneal macrophage activation. J. Med. Virol. 41 (1993) 191-195
18. Dan K., Miyashita K., Seto Y., and Fujita H. Mechanism of the protective effect of heteropolyoxotungstate against herpes simplex virus type 2. Pharmacology 67 (2003) 83-89
19. Shigeta S., Mori S., Watanabe J., Soeda S., Takahashi K., and Yamase T. Synergistic anti-influenza virus A(H1N1) activities of PM-523(polyoxometalate) and Ribavirin in vitro and in vivo. Antimicrob. agents chem. (1997) 1423-1427
20. Fukuda N., Yamase T., and Tajima Y. Inhibitory effect of polyoxotungstates on the production of penicillin-binding proteins and β-Lactamase against methicillin-resistant Staphylococcus aureus. Biol. Pharm. Bull. 22 (1999) 463-470
21. Fukuda N., and Yamase T. In vitro antibacterial activity of vanadate and vanadyl compounds against Streptcoccus pneumoniae. Biol. Pharm. Bull. 20 (1997) 927-930
22. Hojo H. Establishment of cultured cell line of human stomach cancer origin and their morphological characteristics. Niigata-Igakkai Zasshi 91 (1977) 737-752 [in Japanese]
23. Cory A.H., Owen T.C., Barltrop J.A., and Cory J.G. Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays. Cancer Res. 7 (1991) 207-212
24. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation cytotoxicity assays. J. Immunol. Methods 65 (1983) 55-63
25. Scudiero D.A., Shoemaker R.H., Paull K.D., Monks A., Tierney S., Nofziger T.H., et al. Evalution of a soluble tetrazolium/formazan assay for cell growth and drug sensitively using human and other tumor cell lines. Cancer Res. 48 (1988) 4827-4833
26. Eriguchi M., Nonaka Y., Yanagie H., Yoshizaki I., Takeda Y., and Sekiguchi M. A molecular biological study of antitumor mechanism of an anti-cancer agent Oxaliplatin against established human gastric cancer cell lines. Biomed. Pharmacother. 57 (2003) 412-415
27. Suzuki H., Seto K., Mori M., Suzuki M., Miura S., and Ishii H. Monochloramine induced DNA fragmentation in gastric cell line MKN45. Am. Physiol. Soc. G (1998) 712-716
28. Tomita K., Yamase T., and Shishido K. Medical chemistry of polyoxometalates Part 2. Enzymatic study on binding of heptamolybdate to DNA. Inorg. Chim. Ata 157 (1989) 167-169
29. Yamase T. Polyoxometalates for molecular devices: antitumor activity and luminescence. Molucular Engineering 3 (1993) 241-262
30. Yamase T. Medical Chemistry of Polyoxometalates Part3. Electrochemical Study of a 1:1 Polyoxomolybdate-Flavin Mononucleotide Complex in Aqueous Solutions. Inorg. Chim. Acta 169 (1990) 147-150